Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Marilyn N Bulloch. (2023) Treatment and prevention of influenza in geriatric patients. Expert Review of Clinical Pharmacology 16:9, pages 825-841.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani, Josuel Ora & Mario Cazzola. (2018) Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents. Expert Opinion on Pharmacotherapy 19:18, pages 2043-2053.
Read now
Read now
Philip J. Spagnuolo, Mengxi Zhang, Yaping Xu, Jian Han, Shuqian Liu, Jinan Liu, Maureen Lichtveld & Lizheng Shi. (2016) Effects of antiviral treatment on influenza-related complications over four influenza seasons: 2006–2010. Current Medical Research and Opinion 32:8, pages 1399-1407.
Read now
Read now
Paolo Preziosi. (2011) Influenza pharmacotherapy: present situation, strategies and hopes. Expert Opinion on Pharmacotherapy 12:10, pages 1523-1549.
Read now
Read now
John G Gums, Elise M Pelletier & William A Blumentals. (2008) Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children. Expert Opinion on Pharmacotherapy 9:2, pages 151-161.
Read now
Read now
William A. Blumentals & Kathy L. Schulman. (2007) Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study. Current Medical Research and Opinion 23:12, pages 2961-2970.
Read now
Read now
Jiang-tao Lin, Xue-zhong Yu, De-jian Cui, Xu‐yan Chen, Ji-hong Zhu, Yu-zhen Wang & Xiao‐di Wu. (2006) A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population. Current Medical Research and Opinion 22:1, pages 75-82.
Read now
Read now
John Oxford. (2005) Oseltamivir in the management of influenza. Expert Opinion on Pharmacotherapy 6:14, pages 2493-2500.
Read now
Read now
Articles from other publishers (37)
Phyo T Htoo, Gregory Measer, Robert Orr, Justin Bohn, Alfred Sorbello, Henry Francis, Sarah K Dutcher, Austin Cosgrove, Amanda Carruth, Sengwee Toh & Noelle M Cocoros. (2022) Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data. American Journal of Epidemiology 191:5, pages 908-920.
Crossref
Crossref
Yogesh Sharma, Chris Horwood, Paul Hakendorf & Campbell Thompson. (2021) Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients. International Journal of Infectious Diseases 104, pages 232-238.
Crossref
Crossref
S Scott Sutton, Joseph Magagnoli, Tammy Cummings & James Hardin. (2021) Association Between the Use of Antibiotics, Antivirals, and Hospitalizations Among Patients With Laboratory-confirmed Influenza. Clinical Infectious Diseases 72:4, pages 566-573.
Crossref
Crossref
Kyeong Hyang Byeon, Jaiyong Kim, Bo Youl Choi, Jin Yong Kim & Nakyoung Lee. (2020) Factors Affecting the Incidence of Hospitalized Pneumonia after Influenza Infection in Korea Using the National Health Insurance Research Database, 2014–2018: Focusing on the Effect of Antiviral Therapy in the 2017 Flu Season. Journal of Korean Medical Science 35:38.
Crossref
Crossref
Aryna Zanuzdana, Karla K?pke & Walter Haas. (2016) Influenza und ambulant erworbene Pneumonie in haus?rztlich t?tigen Arztpraxen in DeutschlandInfluenza and community acquired pneumonia in German primary care. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 59:11, pages 1492-1502.
Crossref
Crossref
Nancy Santesso, Jonathan Hsu, Reem Mustafa, Jan Brozek, Yao Long Chen, Jessica P. Hopkins, Adrienne Cheung, Gayane Hovhannisyan, Liudmila Ivanova, Signe A. Flottorp, Ingvil Sæterdal, Arthur D. Wong, Jinhui Tian, Timothy M. Uyeki, Elie A. Akl, Pablo Alonso‐Coello, Fiona Smaill & Holger J. Schünemann. (2013) Antivirals for influenza: a summary of a systematic review and meta‐analysis of observational studies. Influenza and Other Respiratory Viruses 7:s2, pages 76-81.
Crossref
Crossref
Hoa Van Le, Kathleen J Beach, Gregory Powell, Ed Pattishall, Patrick Ryan & Robertino M Mera. (2011) Performance of a semi-automated approach for risk estimation using a common data model for longitudinal healthcare databases. Statistical Methods in Medical Research 22:1, pages 97-112.
Crossref
Crossref
Charles R. Beck, Rachel Sokal, Nachiappan Arunachalam, Richard Puleston, Anna Cichowska, Anthony Kessel, Maria Zambon & Jonathan S. Nguyen-Van-Tam. (2013) Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic. Influenza and Other Respiratory Viruses 7, pages 14-24.
Crossref
Crossref
M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, R. Read & T.J.M. Verheij. (2011) Guidelines for the management of adult lower respiratory tract infections - Full version. Clinical Microbiology and Infection 17, pages E1-E59.
Crossref
Crossref
M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, R. Read & T.J.M. Verheij. (2011) Guidelines for the management of adult lower respiratory tract infections - Summary. Clinical Microbiology and Infection 17, pages 1-24.
Crossref
Crossref
Susan E. Coffin, Kateri Leckerman, Ron Keren, Matthew Hall, Russell Localio & Theoklis E. Zaoutis. (2011) Oseltamivir Shortens Hospital Stays of Critically Ill Children Hospitalized With Seasonal Influenza. Pediatric Infectious Disease Journal 30:11, pages 962-966.
Crossref
Crossref
Karen M. Clements, Jeremy Chancellor, Kristin Nichol, Kelly DeLong & David Thompson. (2011) Cost-Effectiveness of a Recommendation of Universal Mass Vaccination for Seasonal Influenza in the United States. Value in Health 14:6, pages 800-811.
Crossref
Crossref
Jaime L Rubin, Lisa J McGarry, Keith P Klugman, David R Strutton, Kristen E Gilmore & Milton C Weinstein. (2010) Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic. BMC Infectious Diseases 10:1.
Crossref
Crossref
Jeffrey J. Petrozzino, Cynthia Smith & Mark J. Atkinson. (2010) Rapid Diagnostic Testing for Seasonal Influenza: An Evidence-Based Review and Comparison with Unaided Clinical Diagnosis. The Journal of Emergency Medicine 39:4, pages 476-490.e1.
Crossref
Crossref
R. Dutkowski. (2010) Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. Journal of Antimicrobial Chemotherapy 65:Supplement 2, pages ii11-ii24.
Crossref
Crossref
Pritish K. Tosh, Robert M. Jacobson & Gregory A. Poland. (2010) Influenza Vaccines: From Surveillance Through Production to Protection. Mayo Clinic Proceedings 85:3, pages 257-273.
Crossref
Crossref
Raoul E. Nap, Maarten P. H. M. Andriessen, Nico E. L. Meessen, Marcel J. I. J. Albers & Tjip S. van der Werf. (2010) Pandemic influenza and pediatric intensive care*. Pediatric Critical Care Medicine 11:2, pages 185-198.
Crossref
Crossref
Sandra E. Talbird, Anita J. Brogan & Aleksander P. Winiarski. (2009) Oseltamivir for Influenza Postexposure Prophylaxis. American Journal of Preventive Medicine 37:5, pages 381-388.
Crossref
Crossref
B. R. Ruf & T. Szucs. (2009) Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy. Infection 37:3, pages 186-196.
Crossref
Crossref
Scott A. Harper, John S. Bradley, Janet A. Englund, Thomas M. File, Stefan Gravenstein, Frederick G. Hayden, Allison J. McGeer, Kathleen M. Neuzil, Andrew T. Pavia, Michael L. Tapper, Timothy M. Uyeki & Richard K. Zimmerman. (2009) Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases 48:8, pages 1003-1032.
Crossref
Crossref
Sandra E. Talbird, Anita J. Brogan, Aleksander P. Winiarski & Beate Sander. (2009) Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. American Journal of Health-System Pharmacy 66:5, pages 469-480.
Crossref
Crossref
Allison J. McGeer. (2009) Diagnostic Testing or Empirical Therapy for Patients Hospitalized with Suspected Influenza: What to Do?. Clinical Infectious Diseases 48:S1, pages S14-S19.
Crossref
Crossref
Joseph P. LynchIIIIII. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
1063
1079
.
Raoul E. Nap, Maarten P.H.M. Andriessen, Nico E.L. Meessen, Dinis dos Reis Miranda & Tjip S. van der Werf. (2008) Pandemic Influenza and Excess Intensive-Care Workload. Emerging Infectious Diseases 14:10, pages 1518-1525.
Crossref
Crossref
D. Low. (2008) Reducing antibiotic use in influenza: challenges and rewards. Clinical Microbiology and Infection 14:4, pages 298-306.
Crossref
Crossref
William A. Fischer & Frederick Hayden. 2008. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH
179
192
.
A. McGeer, K. A. Green, A. Plevneshi, A. Shigayeva, N. Siddiqi, J. Raboud & D. E. Low. (2007) Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, Canada. Clinical Infectious Diseases 45:12, pages 1568-1575.
Crossref
Crossref
Raoul E. Nap, Maarten P.H.M. Andriessen, Nico E.L. Meessen & Tjip S. van der Werf. (2007) Pandemic Influenza and Hospital Resources. Emerging Infectious Diseases 13:11, pages 1714-1719.
Crossref
Crossref
Francisco López-Medrano, Jose M. Aguado, Manuel Lizasoain, Dolores Folgueira, Rafael San Juan, Carmen Díaz-Pedroche, Carlos Lumbreras, Jose M. Morales, Juan F. Delgado & Enrique Moreno-González. (2007) Clinical Implications of Respiratory Virus Infections in Solid Organ Transplant Recipients: A Prospective Study. Transplantation 84:7, pages 851-856.
Crossref
Crossref
Eric A. Orzeck, Nianwen Shi & William A. Blumentals. (2007) Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes. Clinical Therapeutics 29:10, pages 2246-2255.
Crossref
Crossref
Kanako Satoh, Ryouichi Nonaka, Akio Ogata, Dai Nakae & Shin-ichi Uehara. (2007) Effects of Oseltamivir Phosphate (Tamiflu) and Its Metabolite (GS4071) on Monoamine Neurotransmission in the Rat Brain. Biological & Pharmaceutical Bulletin 30:9, pages 1816-1818.
Crossref
Crossref
Martin Crusat & Menno D De Jong. (2005) Neuraminidase Inhibitors and their Role in Avian and Pandemic Influenza. Antiviral Therapy 12:4_part_2, pages 593-602.
Crossref
Crossref
Frederick?G. Hayden & Andrew?T. Pavia. (2006) Antiviral Management of Seasonal and Pandemic Influenza. The Journal of Infectious Diseases 194:s2, pages S119-S126.
Crossref
Crossref
M. Brewster, J.R. Smith, R. Dutkowski & R. Robson. (2006) Active metabolite from Tamiflu® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study. Vaccine 24:44-46, pages 6660-6663.
Crossref
Crossref
Masaichi Abe, James Smith, Akinori Urae, Joanne Barrett, Haruki Kinoshita & Craig R Rayner. (2016) Pharmacokinetics of Oseltamivir in Young and Very Elderly Subjects. Annals of Pharmacotherapy 40:10, pages 1724-1730.
Crossref
Crossref
Frederick G Hayden. (2006) Respiratory viral threats. Current Opinion in Infectious Diseases 19:2, pages 169-178.
Crossref
Crossref
Robert Bettis, Dominick Iacuzio, Thomas Jung, Rudolf Fuchs, Rick Aultman & Marlene Gyldmark. (2006) Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents. Clinical Drug Investigation 26:6, pages 329-340.
Crossref
Crossref